Under construction – not a live service
Sign in

2026-526282-25-00RecruitingPhase 1

A Phase 1b Basket Study Evaluating B Cell Depletion in Blood and Tissue by Etentamig or ABBV-519 in Subjects with Moderate to Severe Systemic Lupus Erythematosus (SLE), Rheumatoid Arthritis (RA), or Sjögren's Disease (SjD)

Source: EU CTIS (euclinicaltrials.eu) · Last updated 10 Sept 2026

Next steps

Status (registry)
Recruiting
Phase (registry)
Phase 1
Study type
Interventional
Enrollment
20 (estimated)
First submitted
15 Jun 2026
Start date
17 Sept 2026
Lead sponsor
AbbVie Deutschland GmbH & Co. KG
EU CT number
2026-526282-25-00

What you commit to

  • Study type: Interventional · Phase 1
  • Planned participants: 20
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Charite Research Organisation GmbHBerlinGermanyRecruiting

Are you the coordinator? Confirm the details

This page is information, not medical advice. Discuss any trial with your doctor.